In Vivo CAR-T for Refractory Graves' Disease
NCT07333677
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Graves' Disease
Interventions
BIOLOGICAL:
In Vivo CAR-T Therapy
Sponsor
Shanghai Zhongshan Hospital